 Simona Zarini
Concepts (332)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 7 | 2023 | 1072 | 1.510 |
Why?
| | Leukotrienes | 10 | 2012 | 35 | 1.210 |
Why?
| | Eicosanoids | 7 | 2018 | 54 | 1.080 |
Why?
| | Diabetes Mellitus, Type 2 | 6 | 2023 | 2094 | 0.860 |
Why?
| | 1-Acylglycerophosphocholine O-Acyltransferase | 3 | 2014 | 5 | 0.630 |
Why?
| | Mass Spectrometry | 5 | 2019 | 633 | 0.620 |
Why?
| | Neutrophils | 15 | 2017 | 1176 | 0.600 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 5 | 2019 | 162 | 0.570 |
Why?
| | Arachidonic Acid | 5 | 2017 | 116 | 0.520 |
Why?
| | Lipid Metabolism | 1 | 2019 | 444 | 0.510 |
Why?
| | Arachidonate 5-Lipoxygenase | 9 | 2017 | 45 | 0.510 |
Why?
| | Metabolomics | 1 | 2019 | 521 | 0.450 |
Why?
| | Myeloid Cells | 1 | 2014 | 126 | 0.430 |
Why?
| | Cysteine | 5 | 2011 | 171 | 0.430 |
Why?
| | Sphingolipids | 2 | 2023 | 57 | 0.410 |
Why?
| | Dinoprostone | 6 | 2022 | 184 | 0.390 |
Why?
| | Leukotriene B4 | 9 | 2012 | 48 | 0.380 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2023 | 185 | 0.340 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 160 | 0.330 |
Why?
| | Obesity | 7 | 2023 | 2508 | 0.330 |
Why?
| | Triglycerides | 2 | 2022 | 467 | 0.330 |
Why?
| | Muscle, Skeletal | 4 | 2023 | 1472 | 0.320 |
Why?
| | Peritonitis | 1 | 2009 | 77 | 0.310 |
Why?
| | Diabetic Retinopathy | 3 | 2019 | 149 | 0.310 |
Why?
| | Retina | 5 | 2019 | 263 | 0.300 |
Why?
| | Bone Marrow | 1 | 2009 | 243 | 0.290 |
Why?
| | Phospholipids | 5 | 2018 | 197 | 0.290 |
Why?
| | Cell Communication | 1 | 2009 | 279 | 0.290 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 2006 | 65 | 0.290 |
Why?
| | Macrophages | 5 | 2020 | 1261 | 0.260 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2006 | 140 | 0.260 |
Why?
| | Ceramides | 2 | 2023 | 91 | 0.250 |
Why?
| | Calcimycin | 5 | 2014 | 47 | 0.240 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 77 | 0.230 |
Why?
| | Mitochondrial Diseases | 1 | 2023 | 77 | 0.210 |
Why?
| | Arachidonic Acids | 1 | 2003 | 56 | 0.210 |
Why?
| | Mice | 20 | 2023 | 14863 | 0.210 |
Why?
| | Animals | 28 | 2023 | 31698 | 0.200 |
Why?
| | Leukotriene A4 | 7 | 2009 | 11 | 0.200 |
Why?
| | Leukotriene Antagonists | 2 | 2019 | 41 | 0.180 |
Why?
| | Lipolysis | 1 | 2020 | 39 | 0.170 |
Why?
| | Diabetic Neuropathies | 1 | 2021 | 79 | 0.170 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 347 | 0.170 |
Why?
| | Adipose Tissue | 2 | 2022 | 539 | 0.160 |
Why?
| | Acetates | 1 | 2019 | 95 | 0.160 |
Why?
| | Myofibroblasts | 1 | 2020 | 116 | 0.160 |
Why?
| | Receptors, Leukotriene | 2 | 2011 | 13 | 0.160 |
Why?
| | Quinolines | 1 | 2019 | 129 | 0.150 |
Why?
| | Calcium Ionophores | 2 | 2014 | 3 | 0.140 |
Why?
| | Receptors, Prostaglandin E, EP2 Subtype | 1 | 2017 | 6 | 0.140 |
Why?
| | Humans | 30 | 2023 | 114662 | 0.140 |
Why?
| | Endocannabinoids | 1 | 2017 | 36 | 0.140 |
Why?
| | Hydroxyeicosatetraenoic Acids | 3 | 2011 | 40 | 0.130 |
Why?
| | Lysophospholipids | 2 | 2014 | 65 | 0.130 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 342 | 0.130 |
Why?
| | Inflammation | 6 | 2019 | 2478 | 0.120 |
Why?
| | Lipids | 1 | 2019 | 580 | 0.120 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2014 | 4 | 0.120 |
Why?
| | Ependymoglial Cells | 1 | 2014 | 6 | 0.120 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 24 | 0.120 |
Why?
| | Mice, Inbred C57BL | 9 | 2023 | 4692 | 0.120 |
Why?
| | Group IV Phospholipases A2 | 3 | 2014 | 45 | 0.120 |
Why?
| | Bone Marrow Cells | 3 | 2017 | 267 | 0.120 |
Why?
| | CD40 Antigens | 1 | 2014 | 82 | 0.110 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 3 | 0.110 |
Why?
| | Cell Membrane | 2 | 2007 | 680 | 0.110 |
Why?
| | Insulin | 1 | 2023 | 2078 | 0.110 |
Why?
| | Inflammation Mediators | 3 | 2009 | 477 | 0.110 |
Why?
| | Prostaglandins | 3 | 2011 | 77 | 0.110 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2013 | 84 | 0.110 |
Why?
| | Chromatography, High Pressure Liquid | 5 | 2018 | 470 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4408 | 0.110 |
Why?
| | Cytosol | 2 | 2020 | 208 | 0.110 |
Why?
| | Interleukin-13 | 2 | 2022 | 122 | 0.100 |
Why?
| | Models, Animal | 1 | 2014 | 344 | 0.100 |
Why?
| | Retinal Degeneration | 1 | 2012 | 30 | 0.100 |
Why?
| | Mice, Transgenic | 4 | 2012 | 1947 | 0.100 |
Why?
| | Safflower Oil | 1 | 2012 | 4 | 0.100 |
Why?
| | Culture Media, Conditioned | 2 | 2022 | 105 | 0.100 |
Why?
| | Tandem Mass Spectrometry | 3 | 2021 | 411 | 0.100 |
Why?
| | Intestinal Mucosa | 2 | 2014 | 532 | 0.100 |
Why?
| | Colitis | 1 | 2014 | 223 | 0.100 |
Why?
| | Linoleic Acid | 1 | 2012 | 37 | 0.100 |
Why?
| | Cells, Cultured | 9 | 2017 | 3885 | 0.100 |
Why?
| | Retinal Neovascularization | 1 | 2011 | 20 | 0.100 |
Why?
| | Cardiolipins | 1 | 2012 | 71 | 0.100 |
Why?
| | Intestines | 2 | 2014 | 326 | 0.090 |
Why?
| | Papilledema | 1 | 2011 | 40 | 0.090 |
Why?
| | Leukocytes | 1 | 2012 | 276 | 0.090 |
Why?
| | Phosphatidylglycerols | 1 | 2011 | 20 | 0.090 |
Why?
| | Retinal Diseases | 1 | 2011 | 76 | 0.090 |
Why?
| | Mycoplasma pneumoniae | 1 | 2011 | 28 | 0.090 |
Why?
| | Zebrafish | 1 | 2014 | 411 | 0.090 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2011 | 30 | 0.090 |
Why?
| | Phospholipases A2, Cytosolic | 1 | 2010 | 6 | 0.090 |
Why?
| | Subcutaneous Fat | 2 | 2022 | 70 | 0.090 |
Why?
| | Leukotriene C4 | 3 | 2012 | 12 | 0.090 |
Why?
| | Bone Marrow Transplantation | 2 | 2009 | 239 | 0.090 |
Why?
| | Synovial Membrane | 1 | 2010 | 75 | 0.090 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2010 | 72 | 0.090 |
Why?
| | Neuroglia | 2 | 2009 | 150 | 0.090 |
Why?
| | Heart Failure | 2 | 2013 | 1945 | 0.090 |
Why?
| | Pulmonary Surfactants | 1 | 2011 | 99 | 0.090 |
Why?
| | Rats | 5 | 2022 | 4958 | 0.090 |
Why?
| | Thimerosal | 2 | 2008 | 4 | 0.090 |
Why?
| | Ionophores | 3 | 2006 | 22 | 0.090 |
Why?
| | Retinal Vessels | 3 | 2019 | 50 | 0.090 |
Why?
| | Shock, Hemorrhagic | 1 | 2012 | 199 | 0.080 |
Why?
| | Mice, Knockout | 6 | 2014 | 2568 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2014 | 685 | 0.080 |
Why?
| | Mitochondria | 2 | 2012 | 747 | 0.080 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2004 | 130 | 0.080 |
Why?
| | Zymosan | 1 | 2009 | 64 | 0.080 |
Why?
| | Calcium | 2 | 2006 | 1108 | 0.080 |
Why?
| | Arthritis, Experimental | 1 | 2010 | 130 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2012 | 298 | 0.080 |
Why?
| | Enzymes | 1 | 2009 | 62 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2022 | 1139 | 0.080 |
Why?
| | Metabolic Networks and Pathways | 1 | 2009 | 168 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2011 | 347 | 0.070 |
Why?
| | Lysophosphatidylcholines | 1 | 2007 | 30 | 0.070 |
Why?
| | Pyrazoles | 1 | 2010 | 362 | 0.070 |
Why?
| | Sulfonamides | 1 | 2010 | 445 | 0.070 |
Why?
| | Disease Progression | 1 | 2013 | 2380 | 0.070 |
Why?
| | Adenosine Triphosphatases | 1 | 2007 | 153 | 0.070 |
Why?
| | Athletes | 2 | 2020 | 328 | 0.070 |
Why?
| | Blotting, Western | 4 | 2012 | 1147 | 0.070 |
Why?
| | Hyperglycemia | 1 | 2009 | 291 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2013 | 3532 | 0.060 |
Why?
| | Isoprostanes | 1 | 2005 | 4 | 0.060 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2005 | 6 | 0.060 |
Why?
| | Thromboxanes | 1 | 2005 | 14 | 0.060 |
Why?
| | Fibroblasts | 1 | 2010 | 838 | 0.060 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2006 | 124 | 0.060 |
Why?
| | Phospholipases A | 1 | 2006 | 101 | 0.060 |
Why?
| | Capillary Permeability | 2 | 2019 | 139 | 0.060 |
Why?
| | Bacterial Proteins | 1 | 2011 | 736 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2007 | 333 | 0.060 |
Why?
| | Protein C | 1 | 2004 | 45 | 0.060 |
Why?
| | SRS-A | 1 | 2004 | 28 | 0.060 |
Why?
| | Membrane Proteins | 3 | 2008 | 1018 | 0.060 |
Why?
| | Receptors, IgE | 1 | 2004 | 40 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2006 | 785 | 0.060 |
Why?
| | Ubiquinone | 1 | 2023 | 21 | 0.060 |
Why?
| | Saccharomyces cerevisiae | 1 | 2007 | 476 | 0.060 |
Why?
| | Brain Edema | 1 | 2004 | 60 | 0.060 |
Why?
| | Bronchial Hyperreactivity | 1 | 2004 | 95 | 0.060 |
Why?
| | Electron Transport | 1 | 2023 | 108 | 0.050 |
Why?
| | Mast Cells | 1 | 2004 | 116 | 0.050 |
Why?
| | Rats, Inbred SHR | 2 | 2013 | 41 | 0.050 |
Why?
| | Sodium | 1 | 2004 | 183 | 0.050 |
Why?
| | Subcellular Fractions | 1 | 2003 | 78 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Chromatography, Gel | 1 | 2003 | 122 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 20 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2004 | 206 | 0.050 |
Why?
| | Mice, Inbred ICR | 1 | 2003 | 109 | 0.050 |
Why?
| | Glucose | 2 | 2022 | 896 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 42 | 0.050 |
Why?
| | Encephalitis | 1 | 2004 | 127 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 83 | 0.050 |
Why?
| | Superoxides | 2 | 2019 | 214 | 0.050 |
Why?
| | Lipoxygenase Inhibitors | 3 | 2012 | 36 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 1842 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 237 | 0.050 |
Why?
| | Glutathione Transferase | 2 | 2000 | 93 | 0.050 |
Why?
| | Prostaglandins E, Synthetic | 1 | 2000 | 2 | 0.050 |
Why?
| | Peroxidases | 1 | 2000 | 25 | 0.050 |
Why?
| | Sarcolemma | 1 | 2020 | 29 | 0.050 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 58 | 0.050 |
Why?
| | Myocardium | 2 | 2013 | 913 | 0.050 |
Why?
| | Allergens | 1 | 2004 | 413 | 0.040 |
Why?
| | Diglycerides | 1 | 2020 | 53 | 0.040 |
Why?
| | Lung Diseases, Obstructive | 1 | 2000 | 40 | 0.040 |
Why?
| | Vitamin E | 1 | 2001 | 110 | 0.040 |
Why?
| | Bronchitis | 1 | 2000 | 35 | 0.040 |
Why?
| | Substrate Specificity | 3 | 2008 | 352 | 0.040 |
Why?
| | Organotin Compounds | 1 | 2000 | 3 | 0.040 |
Why?
| | Serine | 1 | 2021 | 126 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2004 | 529 | 0.040 |
Why?
| | Muscle, Smooth | 1 | 2000 | 144 | 0.040 |
Why?
| | Mitochondria, Muscle | 1 | 2020 | 93 | 0.040 |
Why?
| | Neurons | 1 | 2007 | 1280 | 0.040 |
Why?
| | Plant Oils | 1 | 1999 | 26 | 0.040 |
Why?
| | Electroretinography | 1 | 2019 | 40 | 0.040 |
Why?
| | Indoles | 3 | 2012 | 304 | 0.040 |
Why?
| | Cyclopropanes | 1 | 2019 | 81 | 0.040 |
Why?
| | Food Handling | 1 | 1999 | 49 | 0.040 |
Why?
| | Time Factors | 2 | 2008 | 6114 | 0.040 |
Why?
| | Physical Endurance | 1 | 2020 | 232 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2319 | 0.040 |
Why?
| | Phenols | 1 | 1999 | 82 | 0.040 |
Why?
| | Sulfides | 1 | 2019 | 94 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 676 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1518 | 0.040 |
Why?
| | Male | 7 | 2020 | 55583 | 0.040 |
Why?
| | Dietary Fats | 1 | 2020 | 287 | 0.040 |
Why?
| | Adipocytes | 1 | 2020 | 188 | 0.040 |
Why?
| | Endoplasmic Reticulum | 1 | 2020 | 234 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 923 | 0.040 |
Why?
| | Endothelium, Vascular | 3 | 2011 | 847 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 149 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2019 | 181 | 0.040 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2019 | 151 | 0.040 |
Why?
| | Lung Diseases | 1 | 2004 | 701 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 41 | 0.040 |
Why?
| | Lipoxygenase | 1 | 2017 | 12 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2020 | 554 | 0.040 |
Why?
| | Hypersensitivity | 1 | 2001 | 252 | 0.040 |
Why?
| | Cyclic AMP | 1 | 2017 | 227 | 0.030 |
Why?
| | Glycerol | 1 | 2017 | 84 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 385 | 0.030 |
Why?
| | Cytokines | 2 | 2014 | 1840 | 0.030 |
Why?
| | Immunoblotting | 1 | 2017 | 283 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2014 | 1226 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2000 | 966 | 0.030 |
Why?
| | Cyclooxygenase 2 | 2 | 2011 | 164 | 0.030 |
Why?
| | Skin | 1 | 2020 | 655 | 0.030 |
Why?
| | Antioxidants | 1 | 1999 | 530 | 0.030 |
Why?
| | Signal Transduction | 3 | 2017 | 4512 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2009 | 2552 | 0.030 |
Why?
| | Prostaglandin-E Synthases | 1 | 2014 | 6 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2014 | 57 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2014 | 105 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 821 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2017 | 993 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2014 | 154 | 0.030 |
Why?
| | Female | 6 | 2020 | 59493 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2011 | 1629 | 0.030 |
Why?
| | Transplantation Chimera | 1 | 2012 | 51 | 0.030 |
Why?
| | Caspases | 1 | 2013 | 245 | 0.030 |
Why?
| | Capillaries | 1 | 2012 | 91 | 0.030 |
Why?
| | Adult | 4 | 2020 | 30544 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 498 | 0.020 |
Why?
| | Peroxidase | 1 | 2012 | 163 | 0.020 |
Why?
| | Pericytes | 1 | 2011 | 24 | 0.020 |
Why?
| | Middle Aged | 3 | 2020 | 26733 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2014 | 384 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2011 | 66 | 0.020 |
Why?
| | Albumins | 1 | 2011 | 89 | 0.020 |
Why?
| | Lipopeptides | 1 | 2011 | 14 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 113 | 0.020 |
Why?
| | Celecoxib | 1 | 2010 | 38 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2013 | 750 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 135 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2011 | 167 | 0.020 |
Why?
| | Lipoproteins | 1 | 2011 | 159 | 0.020 |
Why?
| | Receptors, Leukotriene B4 | 1 | 2009 | 8 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 590 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 397 | 0.020 |
Why?
| | Biological Transport | 2 | 2004 | 373 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1012 | 0.020 |
Why?
| | Acetyltransferases | 1 | 2008 | 20 | 0.020 |
Why?
| | Acyltransferases | 1 | 2008 | 46 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 797 | 0.020 |
Why?
| | Heart | 1 | 2012 | 612 | 0.020 |
Why?
| | Asthma | 1 | 2001 | 2029 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 430 | 0.020 |
Why?
| | Cell Count | 2 | 2000 | 303 | 0.020 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2007 | 8 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2007 | 71 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 28 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1999 | 1016 | 0.020 |
Why?
| | Phosphatidylethanolamines | 1 | 2007 | 66 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2008 | 522 | 0.020 |
Why?
| | Rabbits | 2 | 1999 | 733 | 0.020 |
Why?
| | Oxygen | 1 | 2011 | 854 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2007 | 201 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2007 | 122 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 1421 | 0.020 |
Why?
| | Membrane Transport Proteins | 1 | 2007 | 138 | 0.020 |
Why?
| | Lung | 2 | 2012 | 3559 | 0.020 |
Why?
| | Gene Deletion | 1 | 2007 | 356 | 0.020 |
Why?
| | Blood Platelets | 2 | 2000 | 351 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9088 | 0.020 |
Why?
| | Blood Pressure | 1 | 2012 | 1538 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2636 | 0.020 |
Why?
| | Biomarkers | 1 | 2014 | 3408 | 0.010 |
Why?
| | Goblet Cells | 1 | 2004 | 16 | 0.010 |
Why?
| | Leukopenia | 1 | 2004 | 27 | 0.010 |
Why?
| | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2004 | 3 | 0.010 |
Why?
| | Benzopyrans | 1 | 2004 | 25 | 0.010 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2004 | 21 | 0.010 |
Why?
| | Ovalbumin | 1 | 2004 | 161 | 0.010 |
Why?
| | Guinea Pigs | 1 | 2004 | 136 | 0.010 |
Why?
| | Nebulizers and Vaporizers | 1 | 2004 | 78 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2004 | 271 | 0.010 |
Why?
| | Hyperplasia | 1 | 2004 | 163 | 0.010 |
Why?
| | Adoptive Transfer | 1 | 2004 | 195 | 0.010 |
Why?
| | Microcirculation | 1 | 2004 | 135 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 260 | 0.010 |
Why?
| | Endotoxins | 1 | 2004 | 211 | 0.010 |
Why?
| | Electric Stimulation | 1 | 2004 | 250 | 0.010 |
Why?
| | Acetylcholine | 1 | 2004 | 166 | 0.010 |
Why?
| | Aerosols | 1 | 2004 | 150 | 0.010 |
Why?
| | Blood-Brain Barrier | 1 | 2004 | 106 | 0.010 |
Why?
| | Organ Size | 1 | 2004 | 434 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 2004 | 314 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2004 | 511 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 431 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2007 | 2218 | 0.010 |
Why?
| | Trachea | 1 | 2004 | 224 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 1143 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1620 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1230 | 0.010 |
Why?
| | Enzyme Induction | 1 | 2000 | 84 | 0.010 |
Why?
| | Blotting, Northern | 1 | 2000 | 193 | 0.010 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2000 | 16 | 0.010 |
Why?
| | Adenylyl Cyclases | 1 | 2000 | 83 | 0.010 |
Why?
| | Apoptosis | 1 | 2009 | 2362 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2004 | 1660 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2004 | 770 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 292 | 0.010 |
Why?
| | Isoenzymes | 1 | 2000 | 283 | 0.010 |
Why?
| | Olive Oil | 1 | 1999 | 3 | 0.010 |
Why?
| | Waste Management | 1 | 1999 | 7 | 0.010 |
Why?
| | Free Radical Scavengers | 1 | 1999 | 78 | 0.010 |
Why?
| | Bronchi | 1 | 2000 | 231 | 0.010 |
Why?
| | Lipoproteins, LDL | 1 | 1999 | 128 | 0.010 |
Why?
| | Sputum | 1 | 2000 | 285 | 0.010 |
Why?
| | Epoxide Hydrolases | 1 | 1997 | 10 | 0.010 |
Why?
| | Bronchoconstriction | 1 | 1998 | 26 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1021 | 0.010 |
Why?
| | Perfusion | 1 | 1997 | 148 | 0.010 |
Why?
| | Chemotaxis | 1 | 1998 | 130 | 0.010 |
Why?
| | Thiophenes | 1 | 1997 | 108 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1578 | 0.010 |
Why?
| | Binding Sites | 1 | 1997 | 1168 | 0.010 |
Why?
| | Erythrocytes | 1 | 1997 | 591 | 0.010 |
Why?
| | Brain | 1 | 2004 | 2371 | 0.010 |
Why?
| | Adolescent | 1 | 2004 | 17841 | 0.000 |
Why?
| | Aged | 1 | 2000 | 19069 | 0.000 |
Why?
|
|
Zarini's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|